Federated Hermes Inc. Sells 19,405 Shares of The Joint Corp. (NASDAQ:JYNT)

Federated Hermes Inc. reduced its position in shares of The Joint Corp. (NASDAQ:JYNT) by 58.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,807 shares of the company’s stock after selling 19,405 shares during the quarter. Federated Hermes Inc.’s holdings in Joint were worth $133,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the company. Strs Ohio grew its stake in Joint by 69.1% in the 3rd quarter. Strs Ohio now owns 25,200 shares of the company’s stock valued at $226,000 after buying an additional 10,300 shares during the last quarter. Skylands Capital LLC grew its position in shares of Joint by 24.5% in the third quarter. Skylands Capital LLC now owns 501,790 shares of the company’s stock valued at $4,511,000 after purchasing an additional 98,900 shares during the last quarter. Verus Capital Partners LLC increased its stake in shares of Joint by 24.0% during the third quarter. Verus Capital Partners LLC now owns 108,370 shares of the company’s stock worth $974,000 after purchasing an additional 20,950 shares during the period. Barclays PLC lifted its holdings in Joint by 29.4% during the 3rd quarter. Barclays PLC now owns 13,725 shares of the company’s stock worth $123,000 after purchasing an additional 3,119 shares during the last quarter. Finally, Quantbot Technologies LP boosted its stake in Joint by 345.0% in the 3rd quarter. Quantbot Technologies LP now owns 4,170 shares of the company’s stock valued at $37,000 after purchasing an additional 3,233 shares during the period. Institutional investors and hedge funds own 76.88% of the company’s stock.

Joint Stock Down 2.0 %

Shares of Joint stock opened at $15.79 on Tuesday. The firm’s 50-day moving average price is $12.17 and its two-hundred day moving average price is $10.21. The company has a market capitalization of $235.90 million, a price-to-earnings ratio of -21.05 and a beta of 1.58. The Joint Corp. has a 12-month low of $7.31 and a 12-month high of $16.35.

Joint (NASDAQ:JYNT) last posted its quarterly earnings results on Thursday, March 7th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.04. Joint had a negative net margin of 9.24% and a positive return on equity of 3.94%. The business had revenue of $30.61 million for the quarter, compared to analyst estimates of $29.63 million. On average, sell-side analysts expect that The Joint Corp. will post 0.13 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on JYNT shares. StockNews.com raised Joint from a “hold” rating to a “buy” rating in a report on Monday. B. Riley boosted their price objective on shares of Joint from $12.00 to $20.00 and gave the company a “buy” rating in a report on Monday. Roth Mkm reaffirmed a “buy” rating and set a $16.00 target price (up from $13.00) on shares of Joint in a report on Friday. Finally, TheStreet cut Joint from a “c-” rating to a “d” rating in a research note on Thursday, March 7th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $22.00.

Joint Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.